Medius Holdings Past Earnings Performance
Past criteria checks 2/6
Medius Holdings has been growing earnings at an average annual rate of 10.9%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 4.1% per year. Medius Holdings's return on equity is 5.7%, and it has net margins of 0.4%.
Key information
10.9%
Earnings growth rate
10.8%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 4.1% |
| Return on equity | 5.7% |
| Net Margin | 0.4% |
| Next Earnings Update | 08 Nov 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Medius Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 259,789 | 1,124 | 28,671 | 0 |
| 31 Mar 24 | 250,782 | 848 | 27,995 | 0 |
| 31 Dec 23 | 247,463 | 1,144 | 27,492 | 0 |
| 30 Sep 23 | 240,444 | 1,276 | 26,851 | 0 |
| 30 Jun 23 | 239,054 | 1,498 | 26,327 | 0 |
| 31 Mar 23 | 234,271 | 1,120 | 26,203 | 0 |
| 31 Dec 22 | 232,619 | 1,297 | 25,734 | 0 |
| 30 Sep 22 | 230,818 | 1,541 | 25,219 | 0 |
| 30 Jun 22 | 226,606 | 1,867 | 24,476 | 0 |
| 31 Mar 22 | 232,085 | 2,430 | 23,462 | 0 |
| 31 Dec 21 | 241,300 | 2,543 | 22,908 | 0 |
| 30 Sep 21 | 247,003 | 2,482 | 22,348 | 0 |
| 30 Jun 21 | 246,787 | 2,065 | 22,059 | 0 |
| 31 Mar 21 | 238,513 | 1,989 | 22,202 | 0 |
| 31 Dec 20 | 223,053 | 1,334 | 21,676 | 0 |
| 30 Sep 20 | 209,805 | 819 | 21,183 | 0 |
| 30 Jun 20 | 210,388 | 951 | 20,694 | 0 |
| 31 Mar 20 | 208,728 | 1,326 | 19,360 | 0 |
| 31 Dec 19 | 207,087 | 134 | 19,180 | 0 |
| 30 Sep 19 | 208,124 | 225 | 19,033 | 0 |
| 30 Jun 19 | 197,691 | -70 | 18,794 | 0 |
| 31 Mar 19 | 189,707 | -253 | 18,058 | 0 |
| 31 Dec 18 | 180,909 | 835 | 17,236 | 0 |
| 30 Sep 18 | 172,487 | 782 | 16,457 | 0 |
| 30 Jun 18 | 168,135 | 741 | 15,773 | 0 |
| 31 Mar 18 | 165,733 | 776 | 15,629 | 0 |
| 31 Dec 17 | 164,606 | 824 | 15,506 | 0 |
| 30 Sep 17 | 163,838 | 863 | 15,334 | 0 |
| 30 Jun 17 | 162,654 | 863 | 15,165 | 0 |
| 31 Mar 17 | 161,660 | 892 | 14,962 | 0 |
| 31 Dec 16 | 162,892 | 918 | 14,824 | 0 |
| 30 Sep 16 | 160,708 | 969 | 14,710 | 0 |
| 30 Jun 16 | 158,400 | 899 | 14,627 | 0 |
| 31 Mar 16 | 156,121 | 733 | 14,526 | 0 |
| 31 Dec 15 | 150,316 | 495 | 14,397 | 0 |
| 30 Sep 15 | 148,878 | 413 | 14,267 | 0 |
| 30 Jun 15 | 146,168 | 433 | 14,113 | 0 |
| 31 Mar 15 | 142,295 | 484 | 13,898 | 0 |
| 31 Dec 14 | 147,656 | 735 | 13,635 | 0 |
| 30 Sep 14 | 147,246 | 803 | 13,372 | 0 |
| 30 Jun 14 | 145,969 | 968 | 13,040 | 0 |
| 31 Mar 14 | 146,339 | 1,031 | 12,861 | 0 |
| 31 Dec 13 | 137,619 | 860 | 12,607 | 0 |
Quality Earnings: 3154 has high quality earnings.
Growing Profit Margin: 3154's current net profit margins (0.4%) are lower than last year (0.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3154 has become profitable over the past 5 years, growing earnings by 10.9% per year.
Accelerating Growth: 3154's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3154 had negative earnings growth (-25%) over the past year, making it difficult to compare to the Healthcare industry average (9.6%).
Return on Equity
High ROE: 3154's Return on Equity (5.7%) is considered low.